What you should know:
1. Curiteva will use $2.2 million to pay off promissory notes and liquidation preferences. The company did not elaborate on what it would use the remaining funds for.
2. Curiteva developed the Sage cervical interbody fusion system and the Aptitude cervical plates.
3. The company is attempting to raise $20 million through the offering.
More articles on surface technology:
2 hospitals losing neurosurgery residency programs
Rothman, Carrum Health partner to expand healthcare benefits into tri-state area
Nexxt Spine to expand headquarters — 4 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
